Exercise in pregnancy may boost Baby's immune markers, study hints
NCT ID NCT07579468
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how much physical activity a pregnant woman does and whether it changes a substance called calprotectin in her baby's cord blood. Calprotectin is linked to infection risk in newborns. The researchers will measure activity levels in 250 mothers and test cord blood right after birth. The goal is to see if regular exercise might help protect babies from infections.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
physical activity level during pregnancy
What this could lead to
If it works, this could help us understand how exercise during pregnancy might influence a baby's immune system and reduce infection risk.
What could go wrong
This is an observational study, not a treatment trial. It only measures a marker in cord blood, so it cannot prove that exercise directly causes any health benefit.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEW BORN are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU de Clermont-Ferrand
RECRUITINGClermont-Ferrand, 63000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact